期刊文献+

来曲唑超长方案对多囊卵巢综合症促排卵的临床观察 被引量:8

clinical study On the effects of long program on letrozole ovulation induction in polycystic ovary syndrome
下载PDF
导出
摘要 目的探讨服用来曲唑(LE)两种不同天数对多囊卵巢综合征(PCOS)不孕症妇女的促排卵的效果。方法 96例促排卵的PCOS不孕症妇女,分为2组,A组56例:于月经周期第3~7天,每日口服来曲唑5mg,B组40例:于月经周期第3~9天,每日口服来曲唑5mg。周期第10天监测卵泡发育,若优势卵泡平均直径<11 mm,则加用HMG,从75 IU/d开始,肌肉注射,每2-3日监测1次卵泡,根据卵泡生长情况,逐渐加量,最大量用至150IU/d;当优势卵泡最大直径≥18 mm或尿LH阳性,肌肉注HCG5000-10 000 IU,诱发排卵,嘱患者于注射日或次日同房;或HCG注射后24h或36h行宫腔内人工授精(intrauterineinsemination,IUI)。比较两组患者的多种临床指标。结果 2组在促排卵治疗中,对两组HMG用量,卵泡成熟所需天数,HCG日子宫内膜厚度,差异有显著性P<0.01);在HCG日≥15mm卵泡个数,三线征阳性率,妊娠率,两组间差异无显著性(P>0.05);卵巢过度刺激综合征(OHSS),两组无统计学意义;两组均无卵泡未破黄素综合征(LUFS)发生。结论 5mg×7d方案,其在卵泡成熟天数,减少HMG用量方面均有优势。 Objective Discuss taking letrozole(LE) on two different days with polycystic ovary syndrome(PCOS) women with infertility of the effect of ovulation induction.Methods 96 cases of ovulation induction in infertile PCOS women,divided into 2 groups,A group of 56 patients: In the menstrual cycle,the third to seven days,daily oral letrozole 5mg,B group,40 patients: The third to ninth day in the menstrual cycle,daily oral letrozole 5mg.The tenth day of the menstrual cycle monitoring of follicular development,If the average diameter of dominant follicle 11 mm,the addition of HMG,starting from 75 IU once daily intramuscular injection,monitored every two to three days once a follicle,according to follicle growth,gradually increase the amount to 150IU per day with the maximum amount;When the dominant follicle diameter ≥ 18 mm or a positive urinary LH,intramuscular injection HCG5000-10000 IU,induce ovulation,tell the patient sexual intercourse at the injection day or the next day;Or 24h or 36h after the HCG injection for IUI(intrauterine insemination,IUI).To compare the two groups a variety of clinical indicators.Results Ovulation induction in both groups,Significant difference was found between two groups in HMG doses,the number of days required for follicular maturation,thickness of endometrium in the HCG days(P〈0.01).No significant difference was found between two groups follicle number of follicles ≥ 15mm in diameter in the HCG day,the positive rate of endmetrial development,pregnancy rate(P〉0.05),No significant difference was found between two groups in Ovarian hyperstimulation syndrome(OHSS),Both groups didn't have luteinizing unruptured follicle syndrome(LUFS).Conclusion The 5mg × 7d program has reduced HMG dosage and the number of days required for follicular maturation advantage.
作者 刘娟 宋燕
出处 《罕少疾病杂志》 2011年第3期21-23,共3页 Journal of Rare and Uncommon Diseases
关键词 来曲唑 促排卵 多囊卵巢综合征 letrozole ovulation induction polycystic ovary syndrome
  • 相关文献

参考文献6

  • 11Mojdeh Salehnia. Autograft of vitrified mouse ov-es using ethyleneglycol as cryoprotectant[J].gxp Anim, 2002, 51(5): 509-512. 被引量:1
  • 2唐蓉辉,汤惠茹,王丽平,陈小琳,王玉洁,吴瑞芳.深圳市汉族育龄妇女多囊卵巢综合症患病率及临床特征分析[J].罕少疾病杂志,2010,17(1):1-5. 被引量:32
  • 3ATAY V, CAM C, MUHCU M, et at. comparlon of letrozole and clomiphene citrate in women with poiycystic ovaries undergoing stimulation[J]. J Int Ned Res, 2006, 34(1): 73-76. 被引量:1
  • 4HANANEL H, ROBERT, CASPER, et al. A new era inovulation induction[J]. Fertil Steril, 2006, 85(2): 277-284. 被引量:1
  • 5Yang MY & Rajarhendran R. morphological and biochemical identification of apoptosis in small, medium, and large bovine follicle and the effects of follicle- stimulating hormone and insulin-like growth factor-I on spontaneous apoptosis in cultured bovine granulose cell Biol Reprod, 2000, 62 (5):1 209-17. 被引量:1
  • 6CASPER R F, MITWALLY M F. Review: aromatase inhibitors for ovulation induction[J]. J Clin Endocrinol Metab, 2006, 91(6): 760-771. 被引量:1

二级参考文献11

  • 1姚树新.多囊卵巢综合征的彩色多普勒超声诊断[J].罕少疾病杂志,2004,11(4):58-59. 被引量:1
  • 2陈子江,赵君利,周凤荣,李媛,赵力新,马增香.济南市汉族育龄妇女PCOS患病状况的初步调查[J].现代妇产科进展,2005,14(6):442-444. 被引量:41
  • 3Knochenhauer ES, Key TJ, Kahsar-Miller R Prevalence of the polycystic ovary syrdrome in unselected black and white women of the Southeastem United States : A prospective study. J Clin Endocrinol Metab 1998; 83: 3078-82. 被引量:1
  • 4Michelmore KF, Balen AH, Dunger DB, Vessey MP. Polycystic ovaries and associated clinical and biochemical features in young women. Clin Endocrinol 1999;, 51:779-86. 被引量:1
  • 5Kumarapeli V, Seneviratne Rde A, Wijeyaratne CN, etct, A simple Screening Approach for Assessing Comunity Prevalence and Phenotype of Polycystic Ovary Syndrome in a Semiurban Population in Sri Lanka, American Journal of Epidemiology, Am J Epidemiol, 2008 Aug 1; 168(3):321-8. 被引量:1
  • 6The Rotterdam ESHRE/ASRM-sponsored RIB consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome(B2(B). Run Reprod, 2004, 19 (1). 41-47. 被引量:1
  • 7曾泽毅,主编.中华妇产科学.第2版.北京:人民卫生出版社,2007,2448-2480. 被引量:1
  • 8金丕焕,主编.医用统计方法.第2版.上每,复旦大学出版社,2006,9. 被引量:1
  • 9Carmiva E. Diagnosis of polycystic ovary syndrome: from NIH criteria to ESHRE-ASRM guidelines. Minerva Girecol, 2004, 56: 1-6. 被引量:1
  • 10Ricardo Azziz. Controversy in clinical endocrinology diagnosis of polycystic ovarian syndrome the Rotterdam criteria are premature. Clin Endocicol Metab, 2006, 91 (3): 781-785. 被引量:1

共引文献31

同被引文献89

引证文献8

二级引证文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部